AzTrials
AzTrials

Doping in SportNCT04203992

Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes

A study testing Videogame in people with Doping in Sport and Performance Enhancing Product Use, run by McGill University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this research is to test the effectiveness of an interactive doping education videogame among student athletes. Specifically, the game will teach athletes aged 13-16 years about the risks of doping and will foster the values, motivation, and behavioural skills needed to avoid temptation and pressure to… Read more about this study

Who is it for?
Ages 13 to 16 yearsHealthy volunteers can take part
What is being tested?
Videogame
Could I receive a placebo?
No, everyone receives an active treatment
How many people
284 participants
Where
No sites listed yet
Study dates
Nov 2020to Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 16 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Subject competes in a competitive sport at the high school level or higher
  • Able to read and understand English

Who cannot join

  • None

Trial locations and contacts

No sites are listed yet.

About this study

Official title: TRUE CHAMPION: An Educational Videogame Intervention for the Prevention of Doping and Supplement Abuse in Teenage Athletes

The purpose of this research is to test the effectiveness of an interactive doping education videogame among student athletes. Specifically, the game will teach athletes aged 13-16 years about the risks of doping and will foster the values, motivation, and behavioural skills needed to avoid temptation and pressure to dope. The investigators hypothesize that student athletes who play the intervention game will have lower use of banned substances and sport supplements, greater intentions to stay clean, and will also show improvements in the cognitive and motivational antecedents to doping when compared to a control condition.

Read the detailed description

284 student athletes will be enrolled in this two-arm quasi-experimental study. The participants will be boys and girls, aged 13 to 16 years who compete in any sport. Participants will be recruited and enrolled through partnerships with their school physical education and/or sport programs. Participants will complete baseline questionnaires assessing demographics, history of sport participation, and psychological variables related to doping prevention including knowledge, doping self-regulatory efficacy, motivation, attitudes, intentions, perceived norms, doping refusal, substance use behaviours, and doping related protective behaviours (e.g., checking the list of ingredients on medications). Participants will then be assigned to either an intervention group (n = 142; the doping videogame the investigators are developing) or a comparison group (n = 142). The comparison group will be given printed educational materials about doping education, developed by an accredited source (e.g., UNESCO). Assignment to the intervention or comparison group will be conducted at the level of the school to reduce the potential for contamination that could occur if intervention and comparison students were interacting in their school environment and sharing information they learned from the game. Participants from the intervention group will play five, 60-minute sessions over the course of one month (5 hours of total gameplay). Before the gameplay sessions begin, the Project Director and research assistants will orient the intervention group participants to the use of the intervention videogame. Players will be given a tutorial on an iPad demonstrating the mechanics of the game and how to use the iPad. Each player will have their own dedicated iPad that they will use during each game play session (this will be provided by the research team). Shortly after the last gameplay session is completed, participants from both groups will be asked to complete a questionnaire assessing the same psychological variables assessed at baseline as well as their gameplay experience. The psychological variables will also be assessed at three, six, and 12 month follow-ups.

Being tested
Videogame, Control
Keywords
Student athletes, Supplements, Videogame

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VideogameBehavioural

    True Champion is an educational, values-based game that aims to empower young athletes to make informed decisions to avoid doping.

    Participants engaging in the videogame sessions will encounter a series of thought-provoking situations and knowledge tests. Players will help their assigned character navigate through these curriculum-rich scenarios in order to reach their performance goals in a healthy and ethical way.

  • ControlBehavioural

    Participants will be given an anti-doping booklet prepared by UNESCO. This booklet is considered standard educational material, i.e. what might be presented to young athletes as part of their regular sports curriculum.

Study groups in NCT04203992
Study groupRoleWhat they receive
VideogameExperimentalEducational videogame, five 60-minute sessions over one month
Receives: Behavioral: Videogame
BookletActive comparatorEducational booklet, one session
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Use of banned substances

    Self-reported use of banned substances for performance enhancement or recovery in sport.

    This outcome will be measured using a self-reported questionnaire.

    Scale: Performance-Enhancing Substances and Methods Use

    Minimum value: 1 - extremely unlikely (better outcome)

    Maximum value: 7 - extremely likely (worse outcome)

    Measured: 12 months

  2. Use of sport supplements

    Self-reported use of supplements for performance enhancement or recovery in sport.

    This outcome will be measured using a self-reported questionnaire.

    Scale: Performance-Enhancing Substances and Methods Use

    Minimum value: 1 - extremely unlikely (better outcome)

    Maximum value: 7 - extremely likely (worse outcome)

    Measured: 12 months

  3. Intentions to use banned substances and sport supplements

    Self-reported intentions of using banned substances or supplements for performance enhancement or recovery in sport.

    This outcome will be measured using a self-reported questionnaire.

    Scale: Performance-Enhancing Substances and Methods Use

    Minimum value: 1 - extremely unlikely (better outcome)

    Maximum value: 7 - extremely likely (worse outcome)

    Measured: 12 months

Secondary outcomes (7)
  1. Knowledge

    Knowledge of anti-doping rules, definitions and consequences of doping.

    This outcome will be assessed using a True/False questionnaire.

    Measured: 12 months

  2. Doping Self-Regulatory Efficacy

    Self-efficacy for refusing doping under a variety of pressure situations.

    This outcome will be measured using a validated questionnaire.

    Scale: Doping Self-Regulatory Efficacy

    Minimum value: 1 - no confidence (better outcome)

    Maximum value: 5 - complete confidence (worse outcome)

    Measured: 12 months

  3. Motivation

    Motivations for abstaining from doping.

    This outcome will be measured using an adaptation of a validated questionnaire.

    Scale: Treatment Self-Regulation Questionnaire for the Avoidance of Doping in Sport

    Minimum value: 1 - not true at all (worse outcome)

    Maximum value: 7 - very true (better outcome)

    Measured: 12 months

  4. Attitudes

    Attitudes towards doping in sport.

    This outcome will be measured using a subscale from a validated questionnaire.

    Scale: The Adolescent Sport Doping Inventory

    Minimum value: 1 - strongly disagree (worse outcome)

    Maximum value: 7 - strongly agree (better outcome)

    Note: some items are reverse-scored

    Measured: 12 months

  5. Anti-doping protective behaviours

    Self-reported engagement in behaviours linked to doping abstinence.

    Scale: Microbehaviours

    Minimum value: 1 - never (worse outcome)

    Maximum value: 7 - always (better outcome)

    Measured: 12 months

  6. Doping refusal

    Self-report of having refused a supplement or performance-enhancing substance.

    This outcome will be assessed using a Yes (worse outcome) or No (better outcome) questionnaire.

    Measured: 12 months

  7. Gameplay experience

    Enjoyment and acceptability of the True Champion videogame among players assigned to the intervention condition.

    This outcome will be assessed using a questionnaire we have created. Answers will range from "strongly disagree" to "strongly agree".

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2019
  2. Study startNov 2020 (estimated)
  3. Primary completionDec 2021 (estimated)
  4. Study completionJun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
We aim to enroll 284 male and female student-athletes between the ages of 13 and 16. Participants will be assigned to either an intervention group (n = 142) or a comparison group (n = 142).
Masking
None (open label)
Enrolment
284 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04203992
Sponsor's protocol ID
476-0418
Status last verified
Sep 2020
First submitted
11 Dec 2019
Last updated
16 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Goulet C, Valois P, Buist A, Cote M. Predictors of the use of performance-enhancing substances by young athletes. Clin J Sport Med. 2010 Jul;20(4):243-8. doi: 10.1097/JSM.0b013e3181e0b935.

    PubMed 20606508
  • Boardley I, Smith AL, Mills JP, Grix J, Wynne C., & Wilkins L. Development of Moral Disengagement and Self-Regulatory Efficacy Assessments Relevant to Doping in Sport and Exercise. SportRxiv, 12 Oct. 2017. Web.

  • Chan DK, Dimmock JA, Donovan RJ, Hardcastle S, Lentillon-Kaestner V, Hagger MS. Self-determined motivation in sport predicts anti-doping motivation and intention: a perspective from the trans-contextual model. J Sci Med Sport. 2015 May;18(3):315-22. doi: 10.1016/j.jsams.2014.04.001. Epub 2014 Apr 13.

    PubMed 24793786
  • Nicholls AR, Levy AR, Meir R, Sanctuary C, Jones L, Baghurst T, Thompson MA, Perry JL. The development and validation of the Adolescent Sport Drug Inventory (ASDI) among athletes from four continents. Psychol Assess. 2019 Nov;31(11):1279-1293. doi: 10.1037/pas0000750. Epub 2019 Jul 18.

    PubMed 31318254

Questions about this trial

What is this clinical trial studying?

A study testing Videogame in people with Doping in Sport and Performance Enhancing Product Use, run by McGill University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lindsay R Duncan, PhD (514-398-4184 ext. 00919, lindsay.duncan@mcgill.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Use of banned substances (time frame: 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04203992, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in